Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
The Artemis 2 astronauts will venture deeper into space than any human has gone before. That presents some seriously exciting ...
In modern medicine, antibiotics are among the most powerful tools for preventing and treating life-threatening bacterial ...
Good afternoon, and thank you for joining us on our fourth quarter and full year earnings call. As shown on Slide 3, in the ...
Adaptive Biotechnologies (NASDAQ:ADPT) executives said the company delivered “remarkable” performance in 2025, driven by ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
Smoldering multiple myeloma is an asymptomatic, precancerous condition with abnormal plasma cells and elevated monoclonal protein levels. Smoldering multiple myeloma is a complex, intermediary stage ...
Gus’ former junior rugby league club the Walkerston Wanderers started a group to donate blood and plasma joining a ...
HAPPY and smiley” Melody Aggett was diagnosed with aggressive blood cancer in April last year when she was just four months ...
The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...
Neuberg Sehgal Path Lab, a leading name in diagnostic services, launched a cutting-edge cytogenetics testing technology at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results